Found: 156
Select item for more details and to access through your institution.
Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 993, doi. 10.1111/hepr.14052
- By:
- Publication type:
- Article
Electrochemical Na Insertion and Solid Electrolyte Interphase for Hard-Carbon Electrodes and Application to Na-Ion Batteries.
- Published in:
- Advanced Functional Materials, 2011, v. 21, n. 20, p. 3859, doi. 10.1002/adfm.201100854
- By:
- Publication type:
- Article
C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12058-y
- By:
- Publication type:
- Article
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11431-1
- By:
- Publication type:
- Article
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 851, doi. 10.1007/s40121-020-00329-y
- By:
- Publication type:
- Article
Functional characterization of a ClC-2-like Cl(-) conductance in surface epithelial cells of rat rectal colon.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Ex Vivo Experimental Study of the Ablation Area of Bovine Liver Using STARmed Radiofrequency Ablation.
- Published in:
- In Vivo, 2023, v. 37, n. 3, p. 1047, doi. 10.21873/invivo.13179
- By:
- Publication type:
- Article
An Investigation of Popping During Radiofrequency Ablation After Lenvatinib Administration for Hepatocellular Carcinoma.
- Published in:
- In Vivo, 2023, v. 37, n. 2, p. 836, doi. 10.21873/invivo.13150
- By:
- Publication type:
- Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
- By:
- Publication type:
- Article
Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1419, doi. 10.3390/jcm10071419
- By:
- Publication type:
- Article
Electrophysiological characterization of native Na<sup>+</sup>–HCO<sub>3</sub><sup>–</sup> cotransporter current in bovine parotid acinar cells.
- Published in:
- Journal of Physiology, 2005, v. 568, n. 1, p. 181, doi. 10.1113/jphysiol.2005.088633
- By:
- Publication type:
- Article
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
- By:
- Publication type:
- Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
- By:
- Publication type:
- Article
Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 694, doi. 10.1111/apt.17088
- By:
- Publication type:
- Article
Clinical Efficacy and Body Composition Changes with Sodium Glucose Cotransporter 2 Inhibitor/Glucagon-like Peptide-1 Antagonist Combination Therapy in Patients with Type 2 Diabetes Mellitus-associated Nonalcoholic Fatty Liver Disease.
- Published in:
- Internal Medicine, 2024, v. 63, n. 18, p. 2491, doi. 10.2169/internalmedicine.3259-23
- By:
- Publication type:
- Article
Ascending Colon Varices Due to Left-sided Portal Hypertension.
- Published in:
- Internal Medicine, 2021, v. 60, n. 21, p. 3341, doi. 10.2169/internalmedicine.7334-21
- By:
- Publication type:
- Article
Ascending Colon Varices Due to Left-sided Portal Hypertension.
- Published in:
- Internal Medicine, 2021, v. 60, n. 20, p. 3341, doi. 10.2169/internalmedicine.7334-21
- By:
- Publication type:
- Article
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256
- By:
- Publication type:
- Article
Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 598, doi. 10.1159/000480255
- By:
- Publication type:
- Article
Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 531, doi. 10.1159/000480143
- By:
- Publication type:
- Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
- By:
- Publication type:
- Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
- By:
- Publication type:
- Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
- By:
- Publication type:
- Article
Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 1, p. 51, doi. 10.1111/hepr.13840
- By:
- Publication type:
- Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
- By:
- Publication type:
- Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
- By:
- Publication type:
- Article
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 235, doi. 10.1111/hepr.13739
- By:
- Publication type:
- Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
- By:
- Publication type:
- Article
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1229, doi. 10.1111/hepr.13718
- By:
- Publication type:
- Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
- By:
- Publication type:
- Article
Changes in disease characteristics of primary biliary cholangitis: An observational retrospective study from 1982 to 2016.
- Published in:
- Hepatology Research, 2021, v. 51, n. 2, p. 166, doi. 10.1111/hepr.13586
- By:
- Publication type:
- Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
- Published in:
- Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
- By:
- Publication type:
- Article
Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia.
- Published in:
- Hepatology Research, 2019, v. 49, n. 5, p. 590, doi. 10.1111/hepr.13305
- By:
- Publication type:
- Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
- By:
- Publication type:
- Article
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator‐blinded, active‐controlled trial and a phase III, multicenter, open trial.
- Published in:
- Hepatology Research, 2018, v. 48, n. 6, p. 411, doi. 10.1111/hepr.13045
- By:
- Publication type:
- Article
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade.
- Published in:
- Hepatology Research, 2018, v. 48, n. 3, p. E61, doi. 10.1111/hepr.12927
- By:
- Publication type:
- Article
Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan.
- Published in:
- Hepatology Research, 2016, v. 46, n. 8, p. 734, doi. 10.1111/hepr.12613
- By:
- Publication type:
- Article
Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.
- Published in:
- Hepatology Research, 2016, v. 46, n. 6, p. 521, doi. 10.1111/hepr.12583
- By:
- Publication type:
- Article
Discrepant diagnostic results using two genotyping methods in a chronic hepatitis C patient in serogroup 1.
- Published in:
- Hepatology Research, 2016, v. 46, n. 4, p. 354, doi. 10.1111/hepr.12536
- By:
- Publication type:
- Article
Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E368, doi. 10.1111/hepr.12318
- By:
- Publication type:
- Article
Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve.
- Published in:
- Hepatology Research, 2014, v. 44, n. 11, p. 1056, doi. 10.1111/hepr.12222
- By:
- Publication type:
- Article
Usefulness of combined application of double-filtration plasmapheresis and twice-daily injections of interferon-β in hemodialysis patients with hepatitis C virus genotype 1b infection and a high viral load.
- Published in:
- Hepatology Research, 2014, v. 44, n. 10, p. E257, doi. 10.1111/hepr.12207
- By:
- Publication type:
- Article
Novel additional indication of tolvaptan: Can tolvaptan provide a beneficial therapeutic option in cirrhotic patients with ascites?
- Published in:
- Hepatology Research, 2014, v. 44, n. 1, p. 70, doi. 10.1111/hepr.12137
- By:
- Publication type:
- Article
Case of cerebral lipiodol embolism after repeated transcatheter arterial chemoembolization of hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2013, v. 43, n. 11, p. 1251, doi. 10.1111/hepr.12074
- By:
- Publication type:
- Article
Efficacy of the regimen using twice-daily β-interferon followed by the standard of care for chronic hepatitis C genotype 1b with high viral load.
- Published in:
- Hepatology Research, 2012, v. 42, n. 9, p. 864, doi. 10.1111/j.1872-034X.2012.00995.x
- By:
- Publication type:
- Article
Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C.
- Published in:
- Hepatology Research, 2011, v. 41, n. 2, p. 118, doi. 10.1111/j.1872-034X.2010.00749.x
- By:
- Publication type:
- Article
Radiofrequency ablation is justified for elderly patients with hepatocellular carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Sustained response to interferon-α plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells.
- Published in:
- Hepatology Research, 2008, v. 38, n. 7, p. 664, doi. 10.1111/j.1872-034X.2008.00317.x
- By:
- Publication type:
- Article
Balloon-occluded retrograde transvenous obliteration of gastric varix draining to the IVC via the circumaortic renal vein
- Published in:
- Hepatology Research, 2005, v. 32, n. 2, p. 117, doi. 10.1016/j.hepres.2005.03.011
- By:
- Publication type:
- Article